# Effects of Vasopressors on Immune Response

> **NCT02675868** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Endotoxemia

## Interventions

- **DRUG:** Norepinephrine
- **DRUG:** Phenylephrine
- **DRUG:** Vasopressins
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02675868
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-07
- **Final completion:** 2016-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02675868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02675868, "Effects of Vasopressors on Immune Response". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02675868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*